Tumor models for preclinical development of targeted agents.
Teicher
Beverly A
BA
Genzyme Corporation, 1 Mountain Road, Framingham, MA 01701, USA. Beverly.Teicher@Genzyme.com
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004195:Disease Models, Animal; D015195:Drug Design; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005818:Genetic Engineering; D006801:Humans; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors*; D014183:Transplantation, Heterologous
D000970:Antineoplastic Agents; D066246:ErbB Receptors; D018719:Erb-b2 Receptor Tyrosine Kinases